Aggrastat GPIIb/IIIa inhibitor data

The results of the randomized, double-blind, placebo-controlled RESTORE trial of Aggrastat in 2,139 patients undergoing angioplasty

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE